Social Media Ideas for Tasc Trial

The TASC Trial: Therapeutic vs Prophylactic Anticoagulation for Acute Chest Syndrome

In adults with sickle cell disease hospitalized for acute chest syndrome (ACS) without pulmonary artery macrothrombosis, does therapeutic-dose anticoagulation with tinzaparin short...

MDCalc Wars: Massive Transfusion in Trauma – ABC vs. TASH

The ABC Score is a rapid, 4-variable bedside tool for immediate massive transfusion decisions — before labs are back; TASH provides a more precise probability estimate once labs an...

TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembr...

75.0% Response Rate and Median PFS of 10.9 Months Observed in First-Line Recurrent or Metastatic Head and Neck Cancer(R/M HNSCC)Advancing Tosposertib Toward Next-Stage Development...

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achiev...

- - • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency - • Efdoralpr...

TRIAL OF ESCLATION VERSES EARLY HIGH-EFFICACY TREATMENT…Let’s guess what will happen

You will note there is no ProfK, ProfG, NDG etc on this one because they declined to participate because they were unwilling to randomise any MS-newbie onto a lower efficacy agent....

Trial of early cancer detection test misses primary endpoint

CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.T...

Candidate Passive Sensor Suite Technologies for Tactical Combat Casualty Care Environments: Comparative Assessment Study

Background: The United States Army Institute for Surgical Research conducted an analysis of 3 prototype sensor suites; all candidates were designed to passively document care deliv...

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Pub...

CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical s...

N-acetylcysteine Trials for Preterm Birth Prevention

In a landmark clinical trial that may redefine prenatal care for at-risk pregnancies, researchers have presented compelling evidence supporting the use of antenatal N-acetylcystein...

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentati...

CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinica...

TOBRA Trial: When More Powder Doesn't Mean More Power

Trauma surgeons have long embraced a simple philosophy when it comes to preventing infection in difficult tibial fractures: If some local antibiotics are good, maybe more are bette...

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-...

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the supe...

Agent shows ‘transformational’ benefit in metastatic pancreatic cancer

CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the buzz it created among ASCO Annual Meeting at...

British Heart Foundation - ROMA:Women

Published: July 2026 Summary  The Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative, led by the British Heart Founda...

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple...

First-line NSCLC – Compelling Activity Across All PD-L1 Subgroups

HI-PEITHO Trial: Ultrasound-facilitated, Catheter Directed Fibrinolysis for PE

In patients with intermediate-risk pulmonary embolism (PE), does ultrasound-facilitated, catheter-directed fibrinolysis (US-CDT) plus anticoagulation improve clinical outcomes comp...

Attack – right from onset

Remember stroke management before the HASU and thrombolysis era? It was largely characterised by supportive care, rehabilitation, secondary prevention (aspirin, statins, blood pres...

The "Telomere Rivers" Approach Aiming at an Initial Academic Phase 1 Trial

I expressed some skepticism on the approach of Sentcell. The claim is that under defined circumstances CD4+ T cells will secrete structured extracellular telomere fragments (named...

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS Inhibitor Combination...

Adjuvant aspirin does not improve survival in colorectal cancer

CHICAGO — Low-dose aspirin during adjuvant chemotherapy did not significantly reduce risk for recurrence among unselected patients with stage III colorectal cancer, according to ra...

ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer

According to an abstract released ahead of the ASCO 2026 annual meeting, combining the TROP2-directed ADC with Keytruda slashed the risk of disease progression or death by a whoppi...

The Sacroiliac Joint Fusion and Hip Tango

Two hip OA groups, 4,383 patients in each one. One group had SI joint fusion. One did not. Ten-year follow-up.

The Statin Trial in Progressive MS..It failed:-(

Trial in secondary progressive MS has now been reported and it failed to show a positive effect. We will have to wait for the imaging elements to surface Chataway J, Williams T, Bl...

ASCO: Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on notice

The first-in-class EGFRxHER3 bispecific ADC that BMS paid $800 million for has shown strong phase 3 results from China that suggest it could put up a fight against blockbuster TROP...